Practical AI for Drug Discovery and Preclinical Development Summit

Although no drug on the market has yet been discovered using AI, we're due to witness an instantaneous transformation soon as AI approaches an inflection point in drug discovery thanks to the increase in collaboration between AI tech development and big pharma. This is evidenced by third-party investment in AI-enabled drug discovery more than doubling annually for the last five years.

With ongoing headlines spotlighting GSK, AZ, Novartis, Roche, Bayer, and Sanofi's positive results from their AI-powered drug discovery efforts, industry is teetering on the precipice of a breakthrough and the time to get involved is now!

Uniting computational and analytics experts to successfully capitalize on the transformative power of AI, the Practical AI for Drug Discovery and Preclinical Development Summit is your exclusive industry meeting to:
- Practically implement generative AI/ML tools that merge multiple data sources to better understand and drug new disease targets
- Develop tactics to overcome the data generation bottleneck and strategize on ways to make data universally accessible
- Improve vendor selection and qualification by better identifying new AI-native partners and manage existing partnerships to further integrate AI processes across functions